Market Place
Sourcing Support
India`s Biocon Drops Plan to Launch Weight-Loss Drugs in China
27 Jun 2025 //
REUTERS
Novo Nordisk Supports Patient Access to Wegovy and Safety
26 Jun 2025 //
PR NEWSWIRE
Weight-loss drug Wegovy starts at 17,345 in India
25 Jun 2025 //
ECONOMICTIMES
Novo Nordisk launches weight-loss drug Wegovy in India
25 Jun 2025 //
REUTERS
Novo Nordisk Aims for Heavy Sales in India with Wegovy
24 Jun 2025 //
#N/A
Novo Nordisk Ends Collaboration with Hims & Hers Health
24 Jun 2025 //
PR NEWSWIRE
EMA to Allow Novo to Include Heart Condition in Ozempic Label
24 Jun 2025 //
REUTERS
Novo Shares Fall as Obesity Pipeline Faces Investor Scrutiny
23 Jun 2025 //
REUTERS
Novo Nordisk`s experimental drug results in up to 24% weight loss
21 Jun 2025 //
PRESS RELEASE
Judge backs FDA`s Removal of Ozempic, Wegovy from Shortage list
18 Jun 2025 //
REUTERS
NVIDIA partners with Novo Nordisk and DCAI for drug discovery
13 Jun 2025 //
INDPHARMAPOST
Novo Nordisk plans to Start Late-stage Trials of Obesity Drug
13 Jun 2025 //
GLOBENEWSWIRE
EFPIA Urges EU to Streamline Clinical Trials Under Biotech Act
12 Jun 2025 //
RAPS
Novo Signs $812M Weight-Loss Drug License Deal with Deep Apple
12 Jun 2025 //
REUTERS
Novo Nordisk starts new CagriSema weightloss drug trial
11 Jun 2025 //
REUTERS
ADA 2025: Novo Nordisk showcases new semaglutide data, redefining
10 Jun 2025 //
GLOBENEWSWIRE
Parvus Hedge Fund Increases Novo Nordisk Stake, Ft Reports
09 Jun 2025 //
REUTERS
Novo`s Ozempic Linked to Rare Cases of Serious Eye Disorder
09 Jun 2025 //
REUTERS
Novo Nordisk to present phase 3 hemophilia trials at ISTH 2025
06 Jun 2025 //
PR NEWSWIRE
Exclusive: Wegovy use up 50% among US teens
03 Jun 2025 //
REUTERS
Legal battle Erupts before Novo Nordisk`s Wegovy launch
31 May 2025 //
ECONOMICTIMES
Wegovy Maker Novo Faces Fee Demand After Losing Copycat Drug Laws
29 May 2025 //
REUTERS
Weight-Loss Drug Discounts Fall Short, Copies Face US Crackdown
23 May 2025 //
REUTERS
GLP-1 diabetes drugs like Ozempic may modestly reduce cancer risks
23 May 2025 //
REUTERS
Novo Launches Access Programs As FDA Ban Hits Wegovy Copies
22 May 2025 //
PR NEWSWIRE
Time`s up For Compounders: Novo Offers One-Time Wegovy Deal
22 May 2025 //
FIERCE PHARMA
LifeMD partners Novo Nordisk for $299 Wegovy® Bundle
22 May 2025 //
GLOBENEWSWIRE
Novo Nordisk Foundation, China Answer Call for WHO Donations
21 May 2025 //
FIERCE PHARMA
Novo Foundation Pledges $57 Million to WHO Amid US Funding Gap
21 May 2025 //
REUTERS
IDEA ranks Lilly, AZ as biopharma`s top Innovators, Inventors
20 May 2025 //
FIERCE PHARMA
TGA Seeks Feedback on International Clinical Trial Guidelines
19 May 2025 //
RAPS
From insulin to Ozempic, history of Novo Nordisk`s CEOs
19 May 2025 //
REUTERS
Novo ousts CEO after falling behind in weight loss market
17 May 2025 //
REUTERS
Lars Rebien Sørensen joins Novo Nordisk A/S board
16 May 2025 //
PR NEWSWIRE
Pathos AI`s $365M series D to fund trial of Novo tumor drug
15 May 2025 //
FIERCE BIOTECH
Waters Corp`s India Business Boosted by Weight-Loss Drug Demand
15 May 2025 //
REUTERS
Septerna Reports First Quarter 2025 Financial Results
15 May 2025 //
GLOBENEWSWIRE
AMTF report: Insulin unaffordable for T1D patients in LMICs
14 May 2025 //
EXPRESS PHARMA
Novo strikes $2.2B deal with Septerna to new obesity treatments
14 May 2025 //
REUTERS
Select Trial: Wegovy® reduces cardiovascular events before weight
13 May 2025 //
PR NEWSWIRE
Novo Nordisk: Sogroya effective in children with growth disorders
13 May 2025 //
GLOBENEWSWIRE
Zepbound outperforms Novo`s Wegovy for weight loss in trial
12 May 2025 //
REUTERS
Novo Nordisk A/S: Trading in shares by board members
09 May 2025 //
GLOBENEWSWIRE
Novo Nordisk hopes to see US Wegovy sales recover soon
08 May 2025 //
REUTERS
Novo Nordisk`s Q1 sales up 19% in Danish kroner to DKK 78.1B
07 May 2025 //
GLOBENEWSWIRE
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Novo Nordisk: ECO 2025 - Semaglutide data reveals health benefits
06 May 2025 //
GLOBENEWSWIRE
FDA accepts Novo`s application for oral Wegovy for weight loss
03 May 2025 //
REUTERS
Novo Nordisk: CVS Caremark selects Wegovy as preferred obesity
01 May 2025 //
PR NEWSWIRE
Essence trial, Semaglutide improves MASH in adults at 72 weeks
30 Apr 2025 //
PR NEWSWIRE
Novo Nordisk to sell Wegovy via telehealth to US customers
29 Apr 2025 //
REUTERS
Ro, NovoCare Partner to Offer Wegovy® at Lowest Price
29 Apr 2025 //
PR NEWSWIRE
Hims & Hers, Novo Nordisk Partner to Expand Access to Care
29 Apr 2025 //
BUSINESSWIRE
Novo Nordisk`s obesity drug Wegovy debuts in Thailand
29 Apr 2025 //
REUTERS
Ozempic copies restricted after US judge denies injunction
26 Apr 2025 //
REUTERS
Novo protects US patients with legal wins against compounder
25 Apr 2025 //
PR NEWSWIRE
Novo Nordisk applies for FDA approval of semaglutide obesity pill
23 Apr 2025 //
FIERCE PHARMA
Novo Nordisk discontinues India`s top-selling insulin brand
22 Apr 2025 //
ECONOMICTIMES
BMO says Lilly is pulling ahead of Novo in obesity market battle
18 Apr 2025 //
FIERCE PHARMA
OpenFold AI Research Consortium Welcomes New Members
15 Apr 2025 //
BUSINESSWIRE
